Table 4.
Correlations between β-carotene and ubiquinone status and the risk of metabolic syndrome in subjects with oral cancer
| Metabolic syndrome 3 | p values | |
|---|---|---|
| Odds ratios [95% confidence interval] | ||
| β-carotene / LDL-C | ||
| < 81.3 nmol/mmol | 1.00 | – |
| ≥ 81.3 nmol/mmol 1 | 0.59 [0.29–1.19] | 0.14 |
| < 120 nmol/mmol | 1.00 | – |
| ≥ 120 nmol/mmol 2 | 0.41 [0.20–0.85] | 0.02 |
| Ubiquinone / LDL-C | ||
| < 102 nmol/mmol | 1.00 | – |
| ≥ 102 nmol/mmol 1 | 0.67 [0.33–1.38] | 0.28 |
| < 125 nmol/mmol | 1.00 | – |
| ≥ 125 nmol/mmol 2 | 0.42 [0.19–0.89] | 0.02 |
1 The data in this table were analyzed by logistic regression. Antioxidant vitamins status were stratified by the median value of all subjects. 2 Antioxidative vitamins status were stratified by the median value of subjects without metabolic syndrome. 3 The diagnostic criteria for metabolic syndrome in Taiwan are based on the guidelines of the Administration of Health Promotion, Ministry of Health and Welfare, Taiwan. LDL-C, low density lipoprotein-cholesterol